Diabetic autonomic neuropathy: Evidence for apoptosis in situ in the rat

Neurogastroenterology and Motility

Volumn 16, Issue 3, 2004, Pages 335-345

  Guo, C ^a   Quobatari, A ^a   Shangguan, Y ^a   Hong, S ^a   Wiley, J W ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Apoptosis; Autonomic neuropathy; Caspases; Diabetic neuropathy

Indexed keywords

CASPASE 3; DNA NUCLEOTIDYLEXOTRANSFERASE; INSULIN; STREPTOZOCIN;

ANESTHESIA; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTONOMIC NEUROPATHY; CELL POPULATION; COLON; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; HYPOTHESIS; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INTESTINE; MALE; MYENTERIC PLEXUS; NICK END LABELING; NODOSE GANGLION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL GANGLION; STAINING; VALIDATION PROCESS;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; GANGLIA, AUTONOMIC; GANGLIA, SPINAL; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MYENTERIC PLEXUS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 3042799741     PISSN: 13501925     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2004.00524.x     Document Type: Article

References (36)

1. Ziegler D. Diagnosis and treatment of diabetic autonomic neuropathy. Curr Diabetes Rep 2001; 3: 216-27.
2. Stevens MJ, Dananberg J, Feldman EL et al. The linked roles of nitric oxide, aldose reductase, and (Na+, K+)-ATPase in slowing of nerve conduction in the streptozotocin diabetic rat. J Clin Invest 1994; 94: 853-9.
3. Tomlinson DR, Fernyhough P, Diemel LT, Maeda K. Deficient neurotrophic support in the aetiology of diabetic neuropathy. Diabet Med 1996; 13: 679-81.
4. Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, Feldman EL. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis 1999; 6: 347-63.
5. Srinivasan S, Stevens M, Wiley JW. Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. Diabetes 2000; 49: 1932-8.
6. Hall KE, Sima AAF, Wiley JW. Voltage-dependent calcium currents are enhanced in rat dorsal root ganglion neurons from the Bio/Bred Worchester diabetic rat. J Physiol 1995; 486: 313-22.
7. Ways DK, Sheetz MJ. The role of protein kinase C in the development of the complications of diabetes. Vitam Horm 2001; 60: 149-93.
8. Nishikawa T, Edelstein D, Brownlee M. The missing link: a single unifying mechanism for diabetic complications. Kidney Int 2000; 58: S26-30.
9. Lee PG, Cai F, Helke CJ. Streptozotocin-induced diabetes reduces retrograde axonal transport in the afferent and efferent vagus nerve. Brain 2002; 941: 127-36.
10. Zanoni JN, de Miranda Neto MH, Bazotte RB, de Souza RR. Morphological and quantitative analysis of the neurons of the myenteric plexus of the cecum of streptozotocin-induced diabetic rats. Arq Neuropsiquiatr 1997; 55: 696-702.
11. Buttow NC, Miranda Neto MH, Bazotte RB. Morphological and quantitative study of the myenteric plexus of the duodenum of streptozotocin-induced diabetic rats. Arq Gastroenterol 1997; 34: 34-42.
12. Dyck PJ, Karnes JL, O'Brien P, Okazaki H, Lais A, Engelstad J. The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol 1986; 19: 440-9.
13. Llewelyn JG, Gilbey SG, Thomas PK, King RH, Muddle JR, Watkins PJ. Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy. A clinicopathological study. Brain 1991; 114: 867-92.
14. Schmeichel A, Schmelzer JD, Low PA. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 2003; 52: 165-71.
15. Li ZG, Zhang W, Grunberger G, Sima AA. Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res 2002; 946: 221-31.
16. Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 283-90.
17. Kishi M, Tanabe J, Schmelzer JD, Low PA. Morphometry of dorsal root ganglion in chronic experimental diabetic neuropathy. Diabetes 2002; 51: 819-24.
18. Schmidt RE. Neuronal preservation in the sympathetic ganglia of rats it chronic streptozotocin-induced diabetes. Brain Res 2001; 921: 256-9.
19. Furlan MM, Molinari SL, Miranda Neto MH. Morphoquantitative effects of acute diabetes on the myenteric neurons of the proximal colon of adult rats. Arq Neuropsiquiatr 2002; 60(3-A): 576-81.
20. Fregonesi CE, Miranda-Neto MH, Molinari SL, Zanoni JN. Quantitative study of the myenteric plexus of the stomach of rats with streptozotocin-induced diabetes. Arq Neuropsiquiatr 2001; 59: 50-3.
21. Spangeus A, El-Salhy M. Myenteric plexus of obese diabetic mice an animal model of human type 2 diabetes. Histol Histopathol 2001; 16: 159-65.
22. Hernandes L, Bazotte RB, Gama P, Miranda-Neto MH. Streptozotocin-induced diabetes duration is important to determine changes in the number and basophily of myenteric neurons. Arq Neuropsiquiatr 2000; 58: 1035-9.
23. Spangeus A, Suhr O, El-Salhy M. Diabetic state affects the innervation of gut in an animal model of human type 1 diabetes. Histol Histopathol 2000; 15: 739-44.
24. Furlan MM, de Miranda Neto MH, Sant'ana Dde M, Molinari SL. Number and size of myenteric neurons of the duodenum of adult rats with acute diabetes. Arq Neuropsiquiatr 1999; 57(3B): 740-5.
25. Li Y, Owyang C. Musings on the wanderer: what's new in our understanding of vago-vagal reflexes? V. Remodeling of vagus and enteric neural circuitry after vagal injury. Am J Physiol Gastrointest Liver Physiol 2003; 285: G461-469.
26. Lee PG, Hohman TC, Cai F, Regalia J, Helke CJ. Streptozotocin-induced diabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in the cervical vagus nerve. Exp Neurol 2001; 170: 149-61.
27. Hall KE, Liu J, Sima AAF, Wiley JW. Impaired inhibitory G protein function contributes to increased calcium levels in rats with diabetic neuropathy. J Neurophysiol 2001; 86: 760-70.
28. Wyllie AH. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev 1992; 11: 95-103.
29. Negoescu A, Lorimier P, Labat-Moleur F et al. In situ apoptotic cell labeling by the TUNEL method: improvement and evaluation of cell preparations. J Histochem Cytochem 1996; 44: 959-68.
30. deBoer RA, van Veldhuisen DJ, van der Wijk J et al. Additional use of immunostaining for active caspase 3 and cleaved actin and PARP fragments to detect apoptosis in patients with chronic heart failure. J Card Fail 2000; 6: 330-7.
31. Green DR. Apoptotic pathways: paper wraps stone blunts scissor. Cell 2000; 102: 1-4.
32. Reddien PW, Caneron S, Horvitz HR. Phagocytosis promotes programmed cell death in C. elegans. Nature 2001; 412: 198-202.
33. Hick L, Van Der Smissen P, Heusterpreute M, Donnay I, De Hertogh R, Pampfer S. Identification of caspase-3 and caspase-activated deoxyribonuclease in rat blastocysts and their implication in the induction of chromatin degradation (but not nuclear fragmentation by high glucose. Bio Reprod 2001; 64: 555-62.
34. Cheng C, Zochodne DW. Sensory neurons with activated caspase-3 survive long-term experimental diabetes. Diabetes 2003; 52: 2363-71.
35. Yu O, Ouyang A. Substance P binding in gastrointestinal tract of nondiabetic BB rat and changes in diabetic BB rat over time. Dig Dis Sci 1999; 44: 749-55.
36. Unger JW, Klitzsch T, Pera S, Reiter R. Nerve growth factor (NGF) and diabetic neuropathy in the rat: morphological investigations of sural nerve, dorsal root ganglion and spinal cord. Exp Neurol 1998; 153: 23-34.